Polo-like kinase (PLK) 4 is a unique member of the PLK family that plays vital roles in centriole biogenesis during mitosis. The localization of PLK4 on centrioles must be precisely regulated during mitosis to ensure correct centriole duplication. However, little is known about the function of PLK4 in mammalian oocyte meiosis. We addressed this question by examining the expression and localization of PLK4 in mouse oocytes and using RNA interference and protein overexpression to investigate its function in meiosis. PLK4 expression peaked at the germinal vesicle breakdown (GVBD) stage, and the protein was localized in the cytoplasm throughout meiotic maturation. Depletion of PLK4 caused meiotic arrest at the GV stage and suppressed CYCLINB1 and CDC2 activities. Moreover, PLK4 depletion prevented the de-phosphorylation of CDC2-Tyr15 in nucleus and induced a decrease in the level of the CDC25C protein.
INTRODUCTION
Polo-like kinases (PLKs) comprise a family of serine/ threonine kinases that are related to the polo gene product of Drosophila melanogaster, which was originally identified from a mutant that displays abnormal mitotic spindle poles [1] . There are five PLKs (PLK1-PLK5) in mammals; PLK1-4 play various roles in mitotic regulation and localize to centrosomes, kinetochores, and central spindle structures during the cell cycle, whereas PLK5 is linked to the DNA damage response [2] . PLK4 is unique in that it possesses a single polo-box domain at the C terminus in contrast to PLK1-3, which have two such domains [3] . In addition, PLK1-4 but not PLK5 possess a kinase domain [4] . PLK4 does not share sequence homology with the other PLKs.
Many studies have revealed the fact that PLK4 is the main regulator of centriole duplication [5] [6] [7] . Overexpressing PLK4 in somatic cells leads to supernumerary centrioles that perturb spindle formation [8] , whereas PLK4 depletion blocks centriole duplication and thereby inhibits cell proliferation [9] . Recent studies have shown that during centriole duplication in human cells, which is triggered at G 1 /S stage, PLK4 is cooperatively recruited to a centrosomal scaffold assembled by the centrosomal CEP 152 and CEP192 proteins, although different levels of these proteins are involved [10] [11] [12] . PLK4 is closely associated with centriole duplication and spindle formation and is abnormally expressed in all cancer cells; for instance, Plk4 mRNA is upregulated in human gastric cancer cells [13] and breast cancer cell lines, and its dysregulation is a hallmark of poor prognosis [14] . PLK4 also plays essential roles in mammalian embryonic development. In homozygous Plk4 knockout mice, embryogenesis is arrested on embryonic day 7.5, which is accompanied by increased apoptosis [15] . In contrast, heterozygous Plk4 knockout mice have normal development but spontaneously develop liver and lung cancers [16] .
PLK4 activity is tightly regulated during centriole biogenesis. PLK4 expression peaks during mitosis, after which the protein is targeted for degradation by autophosphorylation of the residues Ser293 and Thr297 [17, 18] . The transcription of Plk4 is repressed by p53, and PLK4 depletion via RNA interference induces p53-dependent apoptosis [19, 20] .
Although the role of PLK4 in the regulation of centriole duplication is well established, in mammalian oocyte meiosis and early stages of zygote development, the microtubule organizing center (MTOC) rather than the centrosome regulates spindle formation and migration. It is unclear whether PLK4 is involved in these and other meiotic processes. PLK4 is essential for microtubule elongation and nucleation in early stage mouse embryos in the absence of centrioles, and PLK4 deficiency results in monopolar spindle formation. These findings indicate that, in addition to regulating centriole duplication, PLK4 is also important for spindle formation [21] ; however, all previous studies have focused on the role of PLK4 in mitosis, and as such, little is known about its function in the meiotic maturation of mammalian oocytes.
In mammals, oocyte meiosis resumes upon germinal vesicle breakdown (GVBD), which is followed by chromosome alignment, spindle formation and migration, and asymmetrical cytokinesis [22] . The precise regulation of these events ensures normal oocyte maturation and fertilization. This study investigated the role of PLK4 in mouse oocyte meiosis by examining PLK4 expression and localization and performing loss-and gain-of-function experiments. The results demonstrated that PLK4 is essential for meiotic resumption in mouse oocytes in vitro.
MATERIALS AND METHODS

Mouse Oocyte Collection and In Vitro Maturation
Mice of the ICR strain were used in the experiments. Animal care and handling were conducted in accordance with policies regarding the care and use of animals issued by the ethics committee of the Department of Animal Science, Chungbuk National University. Ovaries from 6-to 8-wk-old mice were removed and cut into pieces using a razor blade. The tissue was dissociated in M2 medium (Sigma, St. Louis, MO). Cumulus cells were removed during this process, and only spherical oocytes of similar size were selected. Oocytes were randomly grouped to avoid errors resulting from the inclusion of spontaneously denuded oocytes. Oocytes were maintained at GV stage during microinjection by culturing in M2 medium supplemented with 2.5 lM milrinone. After injection, oocytes were washed thoroughly and cultured in M16 medium (Sigma) covered with liquid paraffin oil at 378C in an atmosphere of 5% CO 2 in air until they had reached GV (0 h), GVBD (2 h), and then stages MI (8 h) and MII (12-14 h ).
Construction of Overexpression Plasmids and In Vitro Transcription
Total RNA was extracted from 150 GV-stage oocytes using Dynabeads mRNA Direct kit (Ambion, Austin, TX). Total cDNA was synthesized using a cDNA synthesis kit (Legene, San Diego, CA). The full-length Plk4 coding DNA sequence (CDS) was cloned by PCR using primers 5 0 -CCCGAATTCC CAAGACCTGCTGGCTTCTC-3 0 (sense) and 5 0 -ATTGCGGCCGCTGTCC TAGCCTTATGACCACT-3 0 (antisense). After sequencing and BLAST comparisons, the full-length Plk4 CDS with a Myc-tag at the 5 0 end was subcloned between the EcoRI and NotI (NEB, Ipswich, MA) restriction sites of the pRN3 vector. The pRN3-Plk4 plasmid was linearized using SfiI (NEB) and purified using a gel extraction kit (GeneAll, Seoul, Korea). The T3 High-Yield capped RNA transcription kit (Ambion) was used to produce capped mRNA, which was purified using an RNeasy Cleanup Kit (Qiagen, Dusseldorf, Germany). The concentration of Plk4 mRNA was determined using a DU 530 analyzer (Beckman, Fullerton, CA). An SP6 High-Yield capped RNA transcription kit (Ambion) was used to produce capped Plk1 mRNA from the pSPORT6-Plk1 (Open Biosystems, Lafayette, CO) plasmid. A high concentration of Plk4/Plk1 mRNA (.2500 lg/ml) was used for overexpression analysis (Supplemental Fig. S1A ; Supplemental Data are available online at www.biolreprod.org).
Microinjection of Plk4-Targeted Short Interfering RNA and Plk4 mRNA
Microinjections were performed within 1 h using a microinjector (Eppendorf, Hamburg, Germany). A solution containing Plk4 mRNA was microinjected into the cytoplasm of each GV-stage oocyte for the overexpression assay. Injected oocytes were cultured in M2 medium supplemented with 2.5 lM milrinone for 2 to 6 h to allow translation of Plk4 mRNA and were then transferred to normal M16 medium.
Plk4-targeted short interfering RNA (siRNA) was purchased from Ambion. The siRNA was diluted to 1 lM and microinjected into GVstage oocytes. After injection, oocytes were maintained at GV stage by culturing for 24 h in M2 medium supplemented with 2.5 lM milrinone to ensure that the target mRNA was depleted. As a control, GV-stage oocytes were injected with nuclease-free water and cultured under the same conditions.
PLK1 Inhibitor Treatment, Immunofluorescence, and Western Blotting
BI2536, an inhibitor of PLK1 activity, was purchased from BioVision (San Francisco, CA). To examine the effects of PLK1 inhibition on oocyte meiosis, mouse oocytes were cultured in M2 medium supplemented with BI2536 at concentrations between 100 nM and 1 lM.
Antibodies to detect PLK1 (product code sc-5585) and CDC25C (product code sc-5620) were purchased from Santa Cruz Biotechnology (Dallas, TX). Antibodies against PLK4 and phospho-CDC2 (Tyr15) were purchased from Abcam (product ab103021; Cambridge, UK) and Cell Signaling Technology (product 4539; Boston, MA), respectively. For immunocytochemistry, oocytes were fixed in 4% paraformaldehyde for 30 min and then treated with 0.5% Triton X-100 for 20 min. After blocking in 1% bovine serum albumin (BSA) for 1 h, oocytes were incubated with the primary antibody (1:50 dilution) at 48C overnight. After five washes in phosphate-buffered saline (PBS) containing 0.05% Tween 20 (PBST), oocytes were incubated with tetramethylrhodamine (TRI-TC)-conjugated anti-rabbit secondary antibody (Life Technologies, Carlsbad, CA) diluted 1:200 in PBST for 1 h at room temperature. After four washes in PBST, oocytes were incubated with a fluorescein isothiocyanate (FITC)-conjugated anti-a-tubulin antibody (Sigma) diluted 1:1000 in PBS. After four washes in PBST, oocytes were incubated for 15 min with Hoechst 33342 dye (0.5 lg/ml) prepared in PBS. Oocytes were mounted on glass slides and examined by laser scanning confocal microscopy (models LSM 510 and 710 META; Zeiss, Oberkochen, Germany).
For Western blotting, mouse oocytes were collected in SDS sample buffer and incubated for 5 min at 1008C. Proteins were separated by SDS-PAGE and transferred to polyvinylidene fluoride membranes, which were blocked in Trisbuffered saline supplemented with Tween 20 (TBST) containing 5% BSA for 2 h and then incubated overnight at 48C with the primary antibody (1:500 dilution). After three 10-min washes in TBST, membranes were incubated for 1 h at 378C with a peroxidase-conjugated secondary antibody (1:2000 dilution). Membranes were processed using SuperSignal West Femto maximum sensitivity substrate (ThermoFisher Scientific, Waltham, MA).
Chromosome Spreading
Chromosome spreads were prepared as previously described [23, 24] . Briefly, oocytes were exposed to acidic Tyrode solution (Sigma) for 1 min at 378C to remove the zona pellucida. After a brief recovery in M2 medium, oocytes were transferred to glass slides and fixed in 1% paraformaldehyde prepared in distilled H 2 O (pH 9.2) containing 0.15% Triton X-100 and 3 mM dithiothreitol. Slides were dried slowly in a humid chamber for several hours and then blocked with 1% BSA in PBS for 1 h at room temperature. Oocytes were incubated with an anti-PLK1/PLK4 primary antibody (1:50 dilution) overnight at 48C. After brief washes with washing buffer, the slides were incubated with Cy5-conjugated anti-rabbit immunoglobulin G (IgG; 1:100 dilution; Invitrogen) for 1 h at room temperature. To colabel the kinetochore marker CREST, slides were blocked for 1 h in 1% BSA and then incubated with anti-CREST antibody (1:50 dilution; Santa Cruz Biotechnology), followed by incubation with TRI-TC-conjugated anti-rabbit IgG (1:100 dilution; Invitrogen) for 1 h at room temperature,. DNA was stained with Hoechst dye (0.5 lg/ml in PBS), and slides were mounted for observation by immunofluorescence microscopy.
p34
cdc2 Activity Analysis
The activity of p34 cdc2 was quantified using the Mesacup CDC2 kinase assay (MBL, Nagoya, Japan), which can yield a correlation coefficient as high as 0.9961 between p34 cdc2 kinase activity (as determined by the CDC2 kinase assay) and histone H1 kinase activity (as measured by radioactive detection). Briefly, 5 ll of oocyte extract (containing 200 oocytes) was mixed with 45 ll of kinase assay buffer (25 mM HEPES, pH 7.5, at 258C containing 10 mM MgCl 2 , 10% MV peptide solution [SLYSSPGGAYC, w/v; MBL], and 0.1 mM ATP). The mixture was incubated for 30 min at 308C. The reaction was terminated by adding 200 ll of PBS containing 50 mM EGTA. Phosphorylation of the MV peptide (Dynal Biotech Asa, Oslo, Norway) was detected by ELISA. The optical density of p34 cdc2 kinase activity in the control group was set to 1, and p34 cdc2 kinase activity was quantified in the carbonylcyanide ptrifluoromethoxyphenylhydrazone or L-3,4-dihydroxyphenylalanine (DOPA) decarboxylase treatment groups. The experiment was repeated three times.
Statistical Analysis
All percentage data were subjected to arcsine transformation prior to statistical analysis. Data were analyzed by using the Student t-test with SPSS software (SPSS Inc., Chicago, IL). A P value of ,0.05 was considered significant.
RESULTS
PLK4 Localization and Expression During Mouse Oocyte Meiotic Maturation
Oocytes were cultured in vitro for 0, 2, 8, or 12 h until they reached the GV, GVBD, MI, and MII stages, respectively. The subcellular distribution of PLK4 during mouse oocyte meiotic maturation was examined by confocal immunofluorescence microscopy. PLK4 was localized in the cytoplasm at the GV stage. After the GVBD stage, PLK4 was distributed throughout the oocyte but was not detected on the spindle (Fig. 1A) . The subcellular localization of PLK4 was also examined by injecting Myc-tagged Plk4 mRNA into mouse oocytes and detecting protein expression with an anti-Myc antibody. These results confirmed that PLK4 is localized mainly in the cytoplasm during meiotic maturation (Supplemental Fig.  S1B ). We next performed Western blotting to determine the expression level of PLK4 during mouse oocyte meiotic LUO AND KIM maturation. A total of 150 oocytes were used, and the result showed that the level of PLK4 protein peaked at the GVBD stage (Fig. 1B) .
Depletion of PLK4 Causes GV-Stage Arrest
To investigate the role of PLK4 in mouse oocyte maturation, Plk4-targeted siRNA was microinjected into mouse oocytes at the GV stage to deplete PLK4 protein ( Fig. 2A and Supplemental Fig. S2 ). After 2 h of culture in M16 medium, the percentage of oocytes at the GVBD stage was significantly lower in the Plk4 knockdown group than in the control group (32.35% 6 7.41% vs. 75.41% 6 6.84%, respectively, P , 0.01) (Fig. 2B) . The percentage of PLK4-depleted oocytes reaching the GVBD stage did not increase with longer culture times, suggesting that depletion of PLK4 arrested meiosis at the GV stage (Fig. 2C) . This arrest was rescued by injection of Plk4 mRNA, indicating that the siRNA specifically targeted Plk4 (67.33% 6 7.10%).
Metaphase-promoting factor (MPF) is the main regulator of GVBD in mammalian oocytes; we therefore examined CDC2 activity by analyzing p34 cdc2 activity and Western blotting of CYCLINB1. Consistent with the previous findings, both the CDC2 activity (Fig. 2D ) and the CYCLINB1 expression (Fig.   2E ) were reduced in PLK4-depleted oocytes (Supplemental Fig. S2 ).
PLK4 Depletion Prevented Dephosphorylation of CDC2-Tyr15 and Reduced Expression of CDC25C
MPF activity is regulated by phosphorylation of CDC25C, which translocates to the nucleus and dephosphorylates CDC2 at Tyr15. We examined the expression and localization of CDC25C and phosphorylated CDC2-Tyr15 in PLK4-depleted mouse oocytes at the GV stage. After culturing in the presence of milrinone for 24 h, microinjected oocytes were transferred to M16 medium (designated as the 0-h time point). Phosphorylated CDC2-Tyr15 was detected by immunofluorescence microscopy after 0.5, 1, 1.5, and 2 h. At 0.5 h, the protein was distributed in both the cytoplasm and nucleus; however, at 1 h, the nuclear signal began to decrease in the control group, and after 2 h, the signal was almost exclusively cytoplasmic. In contrast, the distribution of phosphorylated CDC2-Tyr15 was unaltered in PLK4-depleted oocytes and was observed in both the cytoplasm and the nucleus at all time points (Fig. 3A and Supplemental Fig. S3A ). The signal intensity was also much higher in PLK4-depleted than in control oocytes (Supplemental Fig. S3A-b) . 
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We then investigated the distribution of CDC25C at the 1-h time point, when nuclear CDC2-Tyr15 expression began to decrease in control oocytes. CDC25C signal was observed in nuclei of control oocytes by confocal microscopy. In contrast, in PLK4-depleted oocytes, CDC25C expression was reduced to undetectable levels, with only faint signals close to the plasma membrane ( Fig. 3B and Supplemental Fig. S3B ). Moreover, the expression level of CDC25C was lower, whereas that of phosphorylated CDC2-Tyr15 was higher in PLK4-depleted oocytes than in control oocytes, as determined by Western blotting (Fig. 3C and Supplemental Fig. S2 ).
PLK4 Depletion Alters PLK1 Expression Pattern in Mouse Oocytes
PLK1 phosphorylates CDC25C and is a key regulator of mitosis; we therefore used BI2536, a PLK1 inhibitor, to investigate the role of PLK4 in oocytes in the absence of PLK1 activity. The percentage of oocytes at the GVBD stage after 2 h of culture decreased with increases in BI2536 concentration, and the GVBD rate in each group was as follows: 76.21% 6 5.1% (0 nM), 77.78% 6 3.81% (100 nM), 75% 6 6.33% (200 nM), 73.08% 6 4.90% (300 nM), 62.5% 6 5% (400 nM), 54% 6 8.05% (500 nM), 50.18% 6 3.6% (600 nM), 35.71% 6 7.46% (700 nM), 21.42% 6 2.90% (800 nM), and 12.39% 6 3.14% (900 nM). When oocytes were treated with 1 lM BI2536, none reached the GVBD stage after 2 h of culture (Fig.  4A) ; however, at 24 h, the percentage of oocytes at the GVBD stage was normal. The first polar body was not extruded in oocytes treated with any concentration of BI2536, whereas the control group (0 dosage) had normal first polar body extrusion, and examination by confocal microscopy revealed abnormal spindles (Supplemental Fig. S3B ). In addition, PLK1 was distributed predominantly in large cytoplasmic foci in PLK4-depleted oocytes, in contrast to control oocytes in which the protein was detected mainly near the cortex and in nuclear foci (Fig. 4B) .
To assess the role of PLK4 in BI2536-treated mouse oocytes, PLK4 was overexpressed by microinjection of Plk4 mRNA. Surprisingly, GVBD occurred in 1 lM BI2536-treated oocytes after 2 h culture, and comparable fractions of PLK4-overexpressing and untreated oocytes reached this stage (75.82% 6 6% vs. 74.51% 6 5.46%, respectively; P . 0.05). However, the percentage of oocytes that reached the GVBD stage at 2 h in PLK4-depleted oocytes was similar to that of oocytes with or without Plk1 mRNA injection (32.15% 6 6.43% vs. 34.97% 6 3.50%, respectively; P . 0.05), and these values differed from those of control and Plk4 mRNAinjected oocytes treated with BI2536 (P , 0.01). Overexpressing PLK1 also rescued the GV arrest induced by treatment with a high concentration of BI2536; however, the percentage of these oocytes that reached the GVBD stage was significantly lower than that of untreated PLK4-overexpressing oocytes (20.08% 6 9.74%). We also injected Plk1 or Plk4 mRNA into normal oocytes. The results indicated that overexpressing PLK1 (80% 6 10.1%) or PLK4 (78.31% 6 7.79%) solely had no effects on 2-h GVBD rate in mouse oocytes (Fig. 4C ).
PLK4 Overexpression in Mouse Oocytes Has No Effect on Spindle Formation or First Polar Body Extrusion
In somatic cells and D. melanogaster oocytes, PLK4 overexpression resulted in the overduplication of centrioles and perturbed spindle formation. However, 46.49% 6 6.10% of mouse oocytes injected with Plk4 mRNA reached MII stage, a value that was comparable to control oocytes (48.16% 6 5.34%; P . 0.05) (Fig. 5A) . Immunofluorescence examination LUO AND KIM demonstrated that spindle formation was normal in Plk4 mRNA-microinjected oocytes (Fig. 5B) .
DISCUSSION
The PLK family comprises serine/threonine kinases that modulate various processes including gene expression, centriole duplication, and cell cycle regulation. PLK4 is a unique member of this family, whose function remains controversial. This study investigated the role of PLK4 in meiotic maturation of mouse oocytes.
The cellular localization of a protein reflects its specific function. In mitosis, PLK4 is localized at the centrosome where it is involved in centriole duplication. PLK4 overexpression or depletion perturbs centriole duplication, spindle formation, and consequently, cell cycle. However, there are no centrioles in oocytes, and the meiotic spindle forms from the MTOC [25, 26] . In mouse oocytes, PLK4 was distributed in the cytoplasm throughout meiosis and did not appear to be linked to the nucleus or spindle, as observed by immunofluorescence analyses. However, previous studies in early stage mouse embryos showed that PLK4 is found at spindle poles [21] . As 
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in oocytes, there are no centrioles in the embryo at this stage; this localization therefore indicates that PLK4 plays different roles in meiosis and mitosis. Furthermore, PLK4 expression increased at the GVBD stage, suggesting that it regulates this process.
GVBD is the hallmark of meiotic resumption in mammalian oocytes. During this process, CDC25C must be phosphorylated and enter the nucleus [27, 28] in order to activate MPF, the key regulator of chromosome condensation and nuclear membrane destruction [29] , after which CDC2-Tyr15 is de-phosphorylated [30] . In the meiotic maturation of mouse oocytes, PLK4 depletion reduced the protein level of CDC25C and seemed to block its nuclear entry and resulted in up-regulation and nuclear retention of phosphorylated CDC2-Tyr15, preventing MPF activation and causing GV-stage arrest. These results indicate that PLK4 directly or indirectly influences CDC25C activity and is thus essential for meiotic resumption in mouse oocytes.
PLK1 phosphorylates CDC25C at Ser198 to stimulate the nuclear translocation of CDC25C in human somatic cells [31] . If PLK1 is the key regulator of CDC25C phosphorylation and nuclear translocation, overexpressing PLK1 would be expected to rescue the GVBD defect of PLK4-deficient oocytes; however, these oocytes were also arrested at the GV stage. In contrast, PLK4 overexpression rescued GV arrest in oocytes treated with the PLK1 inhibitor. Previous studies of PLK1 in mouse and porcine oocyte meiosis found that injection of anti-PLK1 antibody or inhibition of PLK1 activity delayed GVBD and affected spindle formation [32] [33] [34] . These findings reveal that PLK4 is essential for meiotic resumption in mammalian oocytes, whereas PLK1 is more important for spindle formation. PLK4 can also phosphorylate CDC25C directly, and immunoprecipitation experiments have demonstrated a physical interaction between PLK4 and PLK1 in mammalian cells [35] , likely explaining why PLK4 depletion in mouse oocytes causes both GV-stage arrest and alteration of PLK1 LUO AND KIM expression. However, in the trematode parasite Schistosoma mansoni, the PLK4 homolog smSAK is unable to induce G 2 /M transition in the absence of endogenous smPLK1 [36] , suggesting that the PLK1 homolog smPLK1 is more important than SmSAK for GVBD regulation and also highlighting the varied roles of PLK4 in different species.
PLK1 localization was highly variable following PLK4 depletion. In control oocytes, PLK1 was detected near the cortex and in nuclear foci adjacent to condensed chromosomes. In contrast, in the absence of PLK4 all PLK1 signals appeared as cytoplasmic foci, which is similar to PLK1 distribution in Taxol-treated oocytes [37] . Nuclear translocation of PLK1 requires a functional bipartite nuclear localization signal sequence at residues 134 to 146 [38] . Failure of PLK1 nuclear translocation and its presence in cytoplasmic foci following PLK4 depletion implies that PLK4 is indispensable for PLK1 transport in mouse oocytes, although the underlying mechanism requires further investigation.
Because loss of PLK4 led to GV-stage arrest in mouse oocytes, PLK4 was overexpressed to determine its role in spindle formation. In D. melanogaster and Xenopus laevis oocytes and somatic cells, PLK4 overexpression leads to centriole overduplication and consequent failure of spindle formation [39] [40] [41] ; however, in the current study, PLK4 overexpression had no effect on spindle formation or extrusion of the first polar body. This discrepancy could be due to two reasons. First, mammalian oocytes lack centrioles, and PLK4 did not localize to any part of the spindle, as observed by confocal microscopy; therefore, PLK4 may not regulate spindle formation or first polar body extrusion in mouse oocytes. Centrioles are also absent during the first five rounds of cell division in mammalian embryonic development, and during this time, PLK4 may localize to spindle poles and regulate microtubule elongation and nucleation, similar to its role in somatic cell mitosis. Second, overexpressed PLK4 was regulated by intracellular autophosphorylation and consequently did not influence mouse oocyte meiotic maturation. In mitosis, PLK4 has an extremely short half-life of only 2 to 3 h [42] . To explain this, further studies are needed to determine whether the occurrence of mouse oocyte meiotic maturation upon PLK4 overexpression is due to its short half-life in meiosis.
In conclusion, the findings presented here indicate that PLK4 is a key regulatory factor for meiotic resumption in mouse oocytes.
